Skip to main content

NICE Medical Technologies Guidance

CEDAR is an External Assessment Group (EAG) to NICE in the Medical Technologies Evaluation Programme (MTEP) and contributes to the development of the published NICE medical technologies guidance. NICE states, "Medical technologies guidance is designed to help the NHS adopt efficient and cost effective medical devices and diagnostics more rapidly and consistently. The types of products which might be included are medical devices that deliver treatment such as those implanted during surgical procedures, technologies that give greater independence to patients, and diagnostic devices or tests used to detect or monitor medical conditions" (NICE, 2011).

CEDAR carries out the following activities during the development of medical technologies guidance:

  • Critique company's clinical and cost evidence submission 
  • Conduct new literature search to identify clinical and cost evidence where required
  • Summarise and critically appraise of newly identified evidence 
  • Critique company's cost model
  • Conduct new economic modelling work where required
  • Attend NICE Medical Technologies Advisory Committee 

Assessment Reports

CEDAR has contributed to the following assessment report topics: Title Publication Date Link MTG78 GaitSmart rehabilitation exercise programme for gait and mobility issues April 2024 NICE Medical Technologies Guidance (MTG78) MTG77 Kurin Lock…

Early Value Assessments (EVA)

CEDAR has contributed to the following Early Value Assessment (EVA) reports: Title Publication Date Link HTE17 Digital health technologies to help manage symptoms of psychosis and prevent relapse in adults and young people: early value assessment…

Late Stage Assessments (LSA)